Erin McEvoy

New testing requirements for the Aspergillus fungus are harming cannabis companies, the lawsuit claims.

Citing a lack of studies on CBD concentrations in products available to consumers, this study tested a larger range of sample products than previous studies.

The merger, 16 months in the planning process, has been called off in a mutual agreement between the two companies.

Today’s “In the News” features a sampling of three recent articles with perspectives on the topic of cannabis brands tied to celebrities.

Americans for Safe Access, the nation’s largest member-based organization promoting safe access to medical cannabis, recently released a detailed report on how disparities in state cannabis testing programs affect the health of patients.

Growing cannabis, both indoors or outdoors, impacts the environment in several significant ways and one challenge of today’s cultivators is to consider how to lessen the negative effects of overwatering, pesticides, energy usage, and plastic pollution.

Pharmaceutical developer Oxford Cannabinoid Technologies recently described the potential of its latest cannabinoid-based immunotherapy treatment.

Growing trend in drug testing: more employers are changing their drug testing policies around cannabis.

Perzimmon #2 Live Dried flower from Industry Processing Solutions receives top honor at the Emerald Cup in the “Innovative Product: Consumable” category.

Cannabis Science and Technology® is pleased to announce the addition of Dominika Gruszecka to its editorial advisory board.

All THC-containing products must be sold exclusively at licensed dispensaries only.

Our sister publication, CURE, recently spoke with Kim Stuck, breast cancer survivor and author of our blog Stuck on Compliance.

A recently published study compared various methods and associated costs of treating difficult-to-treat depression.

Recreational cannabis was approved in the state in June 2021, sales began at the beginning of 2023, and medical cannabis has been legal since 2012.

Recent activity in the Senate focuses on both recreational and medical cannabis regulations and reforms.

To help the mental health of citizens and soldiers, the president of Ukraine called for more support for medical cannabis legalization in the country.

A randomized controlled trial examined the experiences of people with alcohol use disorder after being treated with psilocybin.

Citing a growing interest in bio-based replacements for plastic, one study tested the addition of hemp to other bio-based materials.

A reportedly first-of-its-kind study tested the idea that cannabis use leads to other substance use in young adults.

Cova Pay is new software for cannabis stores designed to address current concerns of business owners.

Several agencies are reportedly working together to review the scheduling of cannabis, with a final decision anticipated to come later this year.

The bill would have expanded cannabis legalization already in place in the country.

The Legalise Cannabis Party introduced a bill in three states simultaneously, calling for the growing and consumption of cannabis for personal use.

ProjectCBD provided a detailed summary of some of the recent research on cannabis for treating irritable bowel disease (IBD).

International seed bank Royal Queen Seeds recently shared feedback from the first growers of their new F1 hybrid seeds.

Verde Leaf president and CEO handed prison sentence due to fraudulent business activity with hemp farmers in three states.

Impacts of cannabis for legal, adult recreational use to be discussed in Indiana study committee period this year.

A new law in Oregon aims to hold landowners responsible for cleanup of illegal cannabis growing operations on their properties.

Cannabis Science Conference Spring was held in Portland, Oregon from April 19-21, 2023. Here we provide a few highlights from the event.

The webinar "Cannabis and Dementia: Unlocking the Potential" was held on June 14, 2023, and featured four panelists’ experiences treating dementia symptoms with cannabis.